Sevoflurane is well known to cause depression of cardiovascular function, but detailed information on its actions on the contractility and reactivity of blood vessels is lacking. We have assessed therefore the direct effect of this anaesthetic on the functional reactivity of isolated rabbit mesenteric artery ring preparations. We found that contractions of endothelium intact rings induced by noradrenaline and phenylephrine were significantly attenuated by 4% sevoflurane; the observation that the maximal tension generation decreased without a significant reduction in pD 2 is consistent with the view that receptor dysfunction was not involved. The effect of sevoflurane was not affected by N Gmonomethyl-L-arginine.
Summary
Sevoflurane is well known to cause depression of cardiovascular function, but detailed information on its actions on the contractility and reactivity of blood vessels is lacking. We have assessed therefore the direct effect of this anaesthetic on the functional reactivity of isolated rabbit mesenteric artery ring preparations. We found that contractions of endothelium intact rings induced by noradrenaline and phenylephrine were significantly attenuated by 4% sevoflurane; the observation that the maximal tension generation decreased without a significant reduction in pD 2 is consistent with the view that receptor dysfunction was not involved. The effect of sevoflurane was not affected by N Gmonomethyl-L-arginine.
Sevoflurane 4% also produced attenuation of noradrenaline-induced contractions of endothelium denuded ring preparations. The contractions of endothelium denuded ring preparations produced by noradrenaline in Ca 2+ -free media in the presence of K + were not affected by 4% sevoflurane, but sevoflurane depressed external Ca 2+ -dependent contractions. When vasodilators (acetylcholine and nitroglycerin) were added to the bathing media in the presence of 2% sevoflurane, the endotheliumdependent relaxation produced by acetylcholine, but not the endothelium-independent relaxation produced by nitroglycerin, was attenuated; superoxide dismutase inhibited the effect of sevoflurane on endothelium-dependent relaxation. These results are consistent with the view that sevoflurane inhibits a adrenoceptor-mediated contractions of isolated rabbit mesenteric artery ring preparations; this effect may be caused by reduced Ca 2+ influx, as estimated from the effect on external Ca 2+ -dependent contractions, but is unlikely to be caused by reduced Ca 2+ release from the sarcoplasmic reticulum of vascular smooth muscle, as estimated from noradrenaline-induced contractions in Ca 2+ -free bathing media. Sevoflurane may selectively attenuate endothelium-dependent relaxation by an oxygen free radical mechanism as opposed to endothelium-independent relaxation. Several studies have demonstrated that volatile anaesthetics can alter endothelium-dependent relaxation in vitro. Thus, Muldoon and colleagues [1] suggested an effect of halothane on the synthesis, release or transport of endothelium-derived relaxing factor (EDRF) in rabbit aorta and canine femoral and carotid arteries and proposed that halothane interferes with EDRF-mediated relaxation of vascular smooth muscle. Stone and Johns [2] have also suggested that halothane, enflurane and isofiurane cause vasoconstriction via inhibition of basal EDRF production, stimulation of the release of an endothelium-derived constricting factor, or both. We have found previously that sevoflurane produced oxygen-derived free radicals which were measured using highly sensitive electron spin resonance spectroscopy and the spin-trap 5,5-dimethyl-pyrrolineiV-oxide. We suggested that sevoflurane selectively impairs endothelium-dependent relaxation compared with endothelium-independent relaxation (produced by nitroglycerin) in canine mesenteric arteries by an oxygen-derived free radical mechanism, mainly because of interaction with EDRF [3] . Enhanced oxygen-derived free radical production has been associated with several vascular abnormalities ranging from loss of endothelial injury to total vascular collapse.
Although administration of some volatile anaesthetics to animals and humans may not always result in peripheral vasodilatation, it is agreed that deep anaesthesia, when induced by these agents, results in dilatation and hypotension [4, 5] . Until recently, it was thought that such anaesthetic-induced vasodilatation was caused exclusively by the effects of these anaesthetics on the central [6] and autonomic nervous systems [7] and on the myocardium [8, 9] , and that concentrations of anaesthetics used to induce surgical anaesthesia could exert direct depressant and vasodilator effects on vascular smooth muscle [10] [11] [12] . Sevoflurane has been reported to decrease coronary flow in pigs [13] and rats [14] ; however, Bernard and colleagues [15] and Crawford and colleagues [16] observed an increase in coronary flow induced by sevoflurane in dogs and rats. This , propranolol (P) 3 x 10" 6 mol litre" 1 , EDTA 2.6 x 10" 5 mol litre" 1 and ascorbic acid (A) 0.5 mmol litre" 1 (added 10 min before the addition of noradrenaline). Concentration-response curves were determined by the method of stepwise cumulative addition of noradrenaline in the absence (a) or presence (b) of sevoflurane; recovery responses to noradrenaline (c) were also determined. Four ring preparations (for time-matched control, 1 %, 2% and 4% sevoflurane) obtained from the same vessel were studied in parallel. Numbers indicate minus logarithm of molar dose.
difference may be caused partly by differences in experimental situations. Here, we report that although sevoflurane attenuated endotheliumdependent relaxation by an oxygen-derived free radical mechanism, the modification elicited by sevoflurane on noradrenaline-induced contraction of endothelium denuded rabbit mesenteric arteries was not attributed to the oxygen-derived free radicals generated (from sevoflurane itself).
Materials and methods
With approval from our institutional Animal Care Committee, we obtained mesenteric arteries from male albino (New Zealand) rabbits (2.0-2.5 kg) after exsanguination during anaesthesia with sodium pentobarbitone 40 mg kg" 1 i.v. Fat and other nonvascular tissues were gently removed from the blood vessels, which were cut into rings (2 mm width; mean weight of the tissue 2.79 (SEM 0.07) mg, n = 57), without disturbing the intimal layer, after immersion in ice-cold modified Krebs-Henseleit solution (mmol litre" 1 ): NaCl 118.0, KC14.7, MgSO 4 1.18, CaCl 2 2.5, KH 2 PO 4 1.18, NaHCO 3 25.0 and 5.5 glucose, aerated with 95% oxygen and 5% carbon dioxide; pH 7.2-7.3. The endothelium was removed from some rings by gently rubbing the luminal surface with a wooden implement. Rings with and without endothelium were prepared from adjacent segments of the same vessel. The rings were suspended in a 10-ml water-jacketed tissue bath (37 °C) with one end tied to a fixed point and the other to a force transducer (Nihon Kohden JB-612T, Tokyo, Japan); changes in isometric force were amplified (Nihon Kohden AP-601G, Tokyo, Japan) and recorded (Nihon Kohden WT-645G, Tokyo, Japan). Before the start of the experiment, the rings were allowed to equilibrate for 90 min in modified Krebs-Henseleit solution which was changed at 15-min intervals. During this time, the rings were stretched to a passive tension of 1.5 g. Endothelial integrity was checked in all experiments by the presence of the characteristic relaxation response to acetylcholine 10" 6 mol litre" 1 . Sevoflurane (MAC value in rabbit 3.70 (SD 0.16) % [17] ) was delivered from a vaporizer (Ohmeda Sevotec 3, Steeton, England) in the oxygen-carbon dioxide mixture aerating the bathing media; the gas was humidified before entering the four-serial tissue baths. The concentration in the resulting gas mixture was monitored continuously by a precalibrated multi-gas anaesthetic agent analyser (Datex Capnomac, Helsinki, Finland). The tissue bath was covered with plastic to prevent the aerating gas from immediately escaping into the atmosphere. To determine the time of equilibration of sevoflurane, the concentration of sevoflurane in the bathing media was measured by gas chromatography (Shimazu GC-9A, Kyoto). It was found that equilibration of the bathing media with sevoflurane (1-4%) was complete within 10 min and that stable bath concentrations were achieved at a sevoflurane-oxygencarbon dioxide mixture flow rate of 300 ml min" 1 of gas flow through the frittered glass discs at the bottom of the four-serial bath chambers. The mean bath anaesthetic concentrations after 30 min equilibration for 1%, 2% and 4% sevoflurane were 2.04 (SEM 0.15), 4.14(0.34) and 8.42 (0.68) x 10" 4 mol litre" 1 (n = 3), respectively. On the basis of this, we chose the preincubation conditions used to assess the effect of sevoflurane on vessel preparations; we used 30 min preincubation. All experiments in the presence of sevoflurane were carried out 30 min after beginning anaesthetic delivery, thereby giving 20 min of exposure of the vessel preparations to the stable concentrations of sevoflurane.
Means (SEM) are given throughout. Two sets of statistical comparisons were made. Student's t test for paired samples was used when comparing two populations. Comparisons of subsequent interventions with controls were made using one-way analysis of variance, followed by Duncan's multiple range test. Differences were considered significant at P < 0.05.
The following drugs and chemicals were used: sevoflurane (Maruishi Pharmaceuticals, Osaka, Japan), (-)-noradrenaline hydrochloride (Sigma Chemical Co., St Louis, MO), L-phenylephrine hydrochloride (Wako Chemicals, Osaka, Japan), acetylcholine chloride (Sigma), nitroglycerin (Nihon Kayaku, Tokyo, Japan), superoxide dismutase (SOD; from bovine blood, 3000 u./mg protein, Sigma), Af G -monomethyl-L-arginine acetate salt (L-NMMA; Sigma), ascorbic acid (Wako Chemicals), indomethacin (Sigma), propranolol hydrochloride (Wako Chemicals), ethylenediaminetetra-acetic acid (EDTA; Wako Chemicals) and glycoletherdiaminetetra-acetic acid (EGTA; Wako Chemicals). All drugs except sevoflurane and indomethacin were dissolved in pure water and diluted in the KrebsHenseleit solution gassed with a mixture of 95% oxygen-5% carbon dioxide before being added to the tissue bath. Indomethacin stock solution was prepared by dissolving three parts indomethacin and one part sodium bicarbonate in distilled water. All other reagents were of analytical grade.
Results
The potentiating effect of several compounds on noradrenaline-induced vascular responses is known to result from protection of the catecholamine from oxidation, and Furchgott [18] recommended testing for this possibility by including in the bathing media sufficient EDTA, a heavy metal chelating agent, to completely inhibit the oxidation of catecholamines. Several other compounds, including ascorbic acid, potentiate noradrenaline by preventing its oxidation [18] . Therefore, EDTA and ascorbic acid were added simultaneously to the bathing media; propranolol and indomethacin were also added to block P adrenoceptors and to prevent volatile anaestheticinduced release of a vasodilating prostanoid from endothelium [2] , respectively, in most experiments. Figure 1 shows the experimental protocol for assessing the effect of sevoflurane on noradrenalineinduced responses of the ring preparations. In all ring preparations tested, the pre-( fig. 1, lane a) and postanaesthetic ( fig. 1, lane c) values did not differ significantly from each other, and the noradrenalineinduced response was stable (time-matched control, fig. ID ) during the experimental period. Therefore, to simplify the presentation of data, preanaesthetic values were used as controls, and data for postanaesthetic and time-matched control values are not presented. Figure 2 shows the effect of sevoflurane 30 min after beginning delivery on the concentration-response curves to noradrenaline and phenylephrine in endothelium intact artery rings; the experimental conditions for the phenylephrine studies were the same as those for noradrenaline depicted in figure 1 . In control experiments, noradrenaline and phenylephrine contracted the ring preparations in a concentration-dependent fashion. Sevoflurane 4% significantly attenuated these responses with rightward shifts of the concentrationcontraction curves and a decrease in the maximum contraction ( fig. 2A, 2B ). Sevoflurane 1 % and 2 % were ineffective (data not shown). Noradrenaline 2.58 x 10" 6 mol litre" 1 elicited approximately 50% of the maximum tension that developed in response to noradrenaline in the absence of sevoflurane (control in fig. 2A ).
We next determined whether or not the endothelium-dependent relaxation induced by acetyl- ; n = number of rabbits from which the mesenteric artery was taken. *P < 0.05, **P < 0.01 vs corresponding control value. 1\)g, B) are taken as 100%, and other data are plotted in relation to them. Each point represents mean (SEM) (n = 5); n = number of rabbits from which the mesenteric artery was taken. *P < 0.05, and **P < 0.01 vs corresponding control value. choline (ACh) was altered by sevoflurane. Relaxation responses to the stepwise cumulative addition of ACh and nitroglycerin were determined in rings contracted to a stable plateau tension by the addition of noradrenaline 2.58 x 10~6 mol litre" 1 in the presence or absence of sevoflurane. Sevoflurane 1 % and 2 % significantly attenuated the response elicited by ACh with a decrease in the maximum contraction ( fig. 2c, 2D) ; the endothelium-independent relaxation induced by nitroglycerin 10~I 2 -10" 5 mol litre" 1 was not affected significantly by the anaesthetic (data not shown). We next determined the effect of SOD on the attenuation of endothelium-dependent relaxations of the ring preparations to ACh 10~7 mol litre" 1 , a concentration that produces approximately 50 % of the maximum relaxation (derived from the data of control in fig. 2c ) produced by 2 % sevoflurane. In this series of experiments, the conditions were similar to those described in figure 2 (c and D) except that a single dose of ACh 10~7 mol litre" 1 , SOD 60 u. ml" 1 , or both, was added. SOD was added simultaneously on commencing sevoflurane delivery or 30 min before precontraction induced by noradrenaline 2.58 x 10~6 mol litre" 1 in the absence of sevoflurane. Sevoflurane reduced ACh-induced relaxations (average percentage of preanaesthetic responses to ACh: 72.4 (14.50), n = 5; P < 0.05 vs preanaesthetic value). This reduction was restored to near normal when ACh was added after sevoflurane was removed from the tissue bath (103.2 (5.92), n = 5). Further, SOD, when added to the bathing media simultaneously with initiation of sevoflurane delivery, almost prevented the sevoflurane-induced attenuation of the relaxation (100.1(4.10), n = 5; P < 0.05 vs sevoflurane); SOD alone (added in a time-matched fashion) had no effect on ACh-induced relaxations (102.3 (2.05), n = 5). This suggests that the effect of sevoflurane on endothelium-dependent relaxation of ring preparations could result from its ability to inactivate released EDRF from endothelial cells in response to ACh, perhaps via generation of oxygen free radicals, possibly superoxide anion radicals (O 2 •"). This finding would appear to fit with our previous data obtained in canine mesenteric artery ring preparations [3] .
Recent evidence has suggested that EDRF may be nitric oxide (NO) or a similar nitrogen oxidecontaining compound [19] . Under pathological conditions, EDRF/NO-can combine with O 2~ in aqueous solution to produce the potentially cytotoxic substance, peroxynitrite (ONOO~) [20] which then decays homolytically after protonation to the hydroxyl radical (HO) and nitrogen dioxide. Therefore, we proposed that O 2 ", produced from sevoflurane itself [3] , could combine with basally released NO- [21] from endothelium, and the resultant ONOO" could damage vascular reactivity. A test of this hypothesis is presented in figures 3 and 4. Contraction of endothelium intact rings induced by noradrenaline was attenuated significantly by 4% sevoflurane (fig. 3A) ; the effect was not modified by . When responses to noradrenaline were determined, indomethacin 5 x 10" 5 mol litre" 1 , propranolol 3 x 10" 6 mol litre" 1 , EDTA 2.6 x 10" 5 mol litre" 1 , ascorbic acid 0.5 mmol litre" 1 and KC1 40 mmol litre" 1 were simultaneously added 10 min before addition of noradrenaline; EDTA and ascorbic acid were omitted when the responses to Ca 2+ were determined. Ca 2+ was omitted from the bathing media and EGTA 0.4 mmol litre" 1 was added; contractions were evoked by noradrenaline and Ca 2+ after confirming lack of effect of KC1 40 mmol litre" 1 . Data in panel A are expressed as tension developed in the absence (time-matched control (Q) or presence of sevoflurane, and shown as mean (SEM) (n = T);n = number of rabbits from which mesenteric artery was taken. In panel B, contractions evoked by CaCl 2 100 mmol litre" 1 in the time-matched control (C) experiments are taken as 100%, and shown as mean (SEM) (n = 5); n = number of rabbits from which mesenteric artery was taken. *P < 0.01 vs corresponding time-matched control value.
the NO-synthase inhibitor L-NMMA ( fig. 3B ). Sevoflurane 4% also attenuated noradrenalineinduced contraction of endothelium denuded ring preparations ( fig. 3D ). The effect elicited by sevoflurane on noradrenaline-induced contraction in endothelium intact or denuded rings was unaffected by SOD (fig. 4) . The reduced response to noradrenaline of the ring preparations caused by sevoflurane was therefore not caused by the NO-and O 2 -~ interaction.
Attempts to evaluate the effect of vasoactive agents in the presence of the oxygen free radical generator sevoflurane [3] are risky; the stability of the vasoactive agents (noradrenaline 10~5 mol litre" 1 , phenylephrine 10" 5 mol litre" 1 , ACh 10~5 mol litre" 1 and nitroglycerin 10~6 mol litre" 1 ) used in the present study during the experiments was therefore investigated. Vascular reactivity to the agents, which were each preincubated with 4 % sevoflurane for 30 min before being added to the tissue bath, was nearly the same as that to the untreated agents (average percentages of the responses to the agents which were preincubated in "aerated-no sevoflurane" bathing media: noradrenaline 95.9(2.71); phenylephrine 99.9(0.60); ACh 99.3(2.37); nitroglycerin 98.2 (1.36); n = 5).
Noradrenaline has been shown to release Ca 2+ from intracellular storage sites, the sarcoplasmic reticulum, in rabbit mesenteric artery [22] . To examine further the effect of sevoflurane on vascular smooth muscle contractility, we studied noradrenaline-induced contraction of the ring preparations in the external Ca
2+
-free conditions in the presence of KC1 40 mmol litre"
1 . The contraction produced by noradrenaline of endothelium denuded ring preparations, which was effectively impaired by 4% sevoflurane under normal experimental conditions, was not affected by 4% sevoflurane in a Ca 
Discussion
The present results demonstrate that sevoflurane may inactivate released EDRF from endothelial cells, in response to ACh, via generation of oxygen free radicals, possibly Cy~. When vessel rings were rinsed thoroughly after treatment with sevoflurane, the response to ACh was completely restored. Thus our data provide strong evidence for the direct inactivation of, but not for the synthesis, release or transport of, EDRF. The fate of O 2~ is unclear. It may react with biological molecules to cause cellular dysfunction or with water to form hydrogen peroxide, a spontaneous reaction the rate of which is enhanced by SOD. The present data support a role for O 2~; sevoflurane-induced attenuation of the endothelium-dependent relaxation caused by ACh was prevented by SOD. If hydrogen peroxide had been involved directly in the effect of sevoflurane, SOD should not have been protective, as the main product of SOD is hydrogen peroxide. Interaction of O 2~ with NO-can lead to the spontaneous formation of the ONOO" radical [20] . Under the appropriate conditions, hydrogen peroxide and ONOO" can generate the highly reactive HO-(see Results). O 2~, in submicromolar concentrations, depresses contractile tension in vessels tonically contracted by noradrenaline [23] . Although this suggests a role for oxidant-dependent attenuation of vascular contraction, the experimental preparation did not allow the investigators to determine if the loss of contractile tension was caused by oxidation and inactivation of noradrenaline or by direct damage of the vascular preparation. If sevoflurane reduced noradrenalineinduced contractile tension by generating O 2~, ONOO", or both, then when endothelial NOsynthase had been inhibited by L-NMMA and when O 2 " generated from sevoflurane itself had been scavenged by SOD, this reduction would be removed. However, in the event, SOD and L-NMMA had no effect, while removal of endothelial cells was also without effect ( figs 3, 4) . Therefore, it appears that the effect of sevoflurane on noradrenalineinduced contractile tone is independent of oxygen free radicals, and that the arterial smooth muscle, rather than the noradrenaline molecule, is the site of action of the anaesthetic. The latter proposal is inferred further from the following observations = (1) the magnitude of the contractile responses of the ring preparations to noradrenaline was unaffected, although noradrenaline was preincubated with sevoflurane for a relatively long time, and (2) sevoflurane attenuated the response of the ring preparations to both noradrenaline and phenylephrine ( fig. 2A and  2B ). AS both agents cause contraction via stimulation of a adrenoceptors, the effect of sevoflurane on noradrenaline-and phenylephrine-induced contractile tone must reflect on action at or after agonistreceptor interaction.
Endothelium-dependent relaxation was more sensitive to sevoflurane than were noradrenaline-and phenylephrine-induced contractions (because endothelium-dependent relaxation was attenuated by 1 % and 2% sevoflurane, while attenuation of the contraction could only be accomplished with 4% sevoflurane) and clearly established a role for oxygen free radicals in the anaesthetic-induced loss of endothelium-dependent relaxation. However, the cellular mechanism involved in sevoflurane-induced loss of noradrenaline contraction remains unclear. Potential sites of action of sevoflurane include a adrenoceptors, alterations in second messenger function, defects in Ca 2+ mobilization and disruption of contractile protein function. The observation that the maximal tension generation decreased without a significant reduction in pD 2 (range: noradrenaline 5.27-5.50; phenylephrine 4.93-5.37; see fig. 2A, 2B) is consistent with the view that receptor dysfunction may not be involved in the effects of sevoflurane.
It has been postulated that the phasic response of vascular smooth muscle is evoked by release of Ca 2+ from the sarcoplasmic reticulum after activation of the influx of Ca
2+
, and that the tonic response is generated by the amount of free Ca 2+ , comprising the Ca 2+ influx, release and uptake at the sarcoplasmic reticulum and Ca 2+ efflux. Noradrenaline can produce both phasic and tonic contractions [24] . It was shown that volatile anaesthetics suppress membrane Ca 2+ and K + channel currents in cardiac myocytes [25, 26] . In in vitro preparations, halothane directly relaxed isolated coronary artery rings contracted previously with K + or prostanoid [27] . This would suggest that volatile anaesthetics are suppressors of voltage-dependent Ca 2+ entry, as voltage-gated Ca
influx is the mechanism underlying K + -induced contractions [28] . On the basis of our results ( fig. 5 ), one could propose that the attenuated noradrenalineinduced contraction of the ring preparations caused by sevofiurane might be produced by a reduced influx of Ca
, possibly through voltage-dependent Ca 2+ channels (because the experiments were carried out in the presence of KC1), rather than by reduced release of Ca 2+ from the sarcoplasmic reticulum. As oxygen free radicals reduce Ca 2+ release from the sarcoplasmic reticulum and activate or sensitize voltage-dependent Ca 2+ channels in vascular smooth muscle [24] , the effect of sevofiurane is thus oxygen free radical-independent.
In conclusion, the results presented here suggest that sevofiurane can inhibit a adrenoceptor-mediated contraction of rabbit mesenteric artery ring preparations; this effect was caused by reduced Ca 2+ influx, as estimated from the effect on external Ca 2+ -dependent contraction, but was unlikely to be caused by reduced Ca 2+ release from the sarcoplasmic reticulum of vascular smooth muscle, as estimated from noradrenaline-induced contraction in Ca
-free bathing media. Sevofiurane may also inactivate released EDRF from endothelial cells in response to ACh.
